FDA Reviews Mifepristone Access as Experts Rebut Tylenol–Autism Claims | CNN2.0

🧪 FDA is reviewing mifepristone’s safety/dispensing despite 25 years of approval, while HHS and FDA leaders outline a reassessment amid broader politicization concerns noted by public health experts.
👶 Doctors counter the President’s posts linking Tylenol (acetaminophen) to autism, stressing no causal evidence and reaffirming it as the only OTC fever treatment approved during pregnancy.
🩺 Dr. Harry Heiman says studies show mixed associations without causation, and untreated high fever in the first trimester carries known risks for congenital and neurodevelopmental problems.
🧬 Mifepristone remains safe and effective through 10 weeks’ gestation, with recent court efforts to restrict access thrown out, though a coalition of GOP attorneys general continues to press limits. 🏛️ Expert concern centers on federal health units being weakened even as agencies revisit established medicines, urging patients to rely on clinicians for evidence‑based guidance.
#Mifepristone #FDA #Tylenol #Pregnancy #Autism #PublicHealth #ReproductiveHealth #CNN2Point0